Ora Biomedical is planting roots in the Puget Sound region with plans to open a drug-discovery laboratory.
The company recently announced a $500,000 pre-seed round from Optispan Ventures, which will help fund a temporary space. Ora Biomedical plans to move into a permanent space at the beginning of 2023, reaching complete operations by May 2023.
“Optispan Ventures and Ora Biomedical have a shared vision of revolutionizing how we age,” said Ora Biomedical CEO Mitchell Lee. “Thanks to our partnership with Optispan, we can accelerate the launch of our longevity drug discovery factory and move one step closer to developing breakthrough healthy aging therapeutics for humans and all other animals we love.”